Canopy Growth Corp is seeing a big jump in its stock price, reflecting positive momentum in the cannabis sector.
Canopy Growth Corp (WEED.TO) is up today, with shares increasing by 5.30% to close at CA$1.39. This rise follows the company's recent quarterly earnings report, which showed impressive revenue growth and a significant reduction in losses, marking a positive turnaround for the cannabis giant.
Investor takeaway: Investors should pay attention to Canopy's strong revenue growth and its focus on high-quality cannabis production, which could indicate a promising outlook for the company's future performance.
Advertisement
Canopy Growth Corp
WEED.TO
WEED.TO
Canopy Growth Corp
WealthAwesomeAdvertisement
Market cap
$614.33M
52W high
$3.28
52W low
$1.18
1W change
+2.33%
Beta
2.41
Analyst Price Targets
Based on analyst covering WEED
Wall Street analysts forecast WEED stock price to rise 53.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.02
+53.0% Upside
Current Price
C$1.32
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on WEED's historical volatility
30-Day Vol
42.1%
Annualized
90-Day Vol
60.3%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$1.10
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.24 | C$1.08 – C$1.44 |
| 60 trading days | C$1.17 | C$0.95 – C$1.44 |
| 90 trading days | C$1.10 | C$0.86 – C$1.42 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Canopy Growth Reports 13% Revenue Growth
The company's net revenue reached CA$81.2 million for Q1 FY2027, indicating a strong recovery trajectory as losses narrowed significantly.
Bull case
The company reported a 13% increase in revenue year-over-year, driven by strong sales in both medical and adult-use cannabis. With a renewed emphasis on quality and consumer-friendly branding, Canopy seems well-positioned to take advantage of the growing demand in the cannabis market.
Bear case
Despite the positive financial results, Canopy still faces challenges, including significant cash outflow and ongoing pressures from changes in reimbursement rates for medical cannabis. Investors should stay cautious about potential volatility in the cannabis sector.
Advertisement
Strong Quarterly Performance
Canopy Growth's recent earnings report revealed a 13% increase in revenue, reaching CA$81.2 million for the first quarter of fiscal 2027. The company saw significant growth in both its medical and adult-use cannabis segments, with medical cannabis revenue climbing 22% year-over-year. This positive performance is a result of strategic initiatives focused on cultivation and cost management.
Market Reactions and Future Outlook
The stock's rise today reflects investor confidence in Canopy's ability to navigate the evolving cannabis landscape. CEO Luc Mongeau emphasized the company's commitment to delivering high-quality products and expanding its market presence. However, investors should remain vigilant about potential challenges, including cash flow issues and regulatory changes affecting the industry.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
